Skip to content
MamaGLP — home

Head to head for first-timers

CoreAge Rx vs Omzo

CoreAge Rx and Omzo both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.

CoreAge Rx

Higher score

Rank #31 for first-timers · Grade C

Mama-Match

Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.

Visit CoreAge Rx
vs

Omzo

Rank #230 for first-timers · Grade C

Mama-Match

Best for: Someone who will open the terms before the cart and compare on $299 rather than on the banner.

Visit Omzo

The verdict for a first step

Higher Mama-Match Score: CoreAge Rx

CoreAge Rx edges out Omzo on the Mama-Match Score, 73 to 49 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.

Omzo is still a genuine option — the homepage says $179. The terms and conditions — where this seller keeps its real price list, six itemized packages of it — say that from the second month on it is $299. They say something else too: that $179 was the previous price and $199 is the current one, which is an increase written with the grammar of a discount. As for the $279 the homepage puts on tirzepatide: it is not in that list. In any position. Weigh the six first-timer factors below against your own priorities.

Side by side on all six factors

Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.

CoreAge Rx Omzo
Gentle, easy start8234
CoreAge
Omzo
Honest, upfront pricing7280
CoreAge
Omzo
Real clinician support8444
CoreAge
Omzo
Available nationwide5550
CoreAge
Omzo
Ongoing help & check-ins7842
CoreAge
Omzo
Simple, fair cancellation5546
CoreAge
Omzo

Price, access and features

DetailCoreAge RxOmzo
Mama-Match Score73/100 · C49/100 · C
Overall rank#31#230
Semaglutide$99/mo$299/mo
Tirzepatide$149/mo$399/mo
CoverageTherapy-specific state restrictions; confirm eligibilityAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only

Mama-Match

CoreAge Rx

Rank #31 · Grade C

What we like

  • Published prices for both molecules, with the same advertised amount at each dose
  • The offer includes medication, consultation and shipping, without an advertised membership fee
  • The legal footer identifies the platform and the entities responsible for clinical care

The caveats

  • The main site and a separate offer page show different prices
  • The FAQ and policy differ on automatic rebilling and denial refunds
  • State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff

Mama-Match

Omzo

Rank #230 · Grade C

What we like

  • An itemized list exists: six packages, each with a first-month and an ongoing price
  • Every package says it includes the consultation, the prescription, the medication, shipping and follow-up
  • Franker than almost anyone here about compounded drugs: not FDA-approved, not reviewed, and no equivalence claimed to any approved medication

The caveats

  • ⛔ The banner says $179 and its own terms say $299: a 40% gap with nothing explaining it
  • ⛔ "Originally priced at $179, currently offered at $199" is a price increase written as though it were a markdown
  • ⛔ The $279 the homepage puts on tirzepatide is not in the price list

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing CoreAge Rx and Omzo with the other providers we review for women.

Or browse the full comparison hub.